CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Portage Biotech Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Portage Biotech Inc
Clarence Thomas Building, Road Town
P.O. Box 4649
Phone: (416) 929-1806p:416 929-1806 TORTOLA, ON  VG1110  Virgin Islands (British) Ticker: BNTNF BNTNF
Business Summary
Portage Biotech Inc. is a clinical-stage immuno-oncology company. The Company is advancing therapies to improve long-term treatment response and quality of life in patients with cancers. The Company’s access to technologies coupled with biological mechanisms enables the identification of clinical therapies and product development strategies, which accelerate these medicines through the translational pipeline. The Company’s portfolio consists of six diverse platforms, with programs including invariant natural killer T cell (iNKT) agonists, which includes PORT-2 and PORT-3, therapies that activate the innate and adaptive immune system. The Company’s portfolio also includes small molecule adenosine inhibitors, such as PORT-6, PORT-7, PORT-8 and PORT-9, which represent of targeting the adenosine pathway. Within these six platforms, the Company has 14 products in development with multiple clinical readouts.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20233/31/2023YesYes---

Industries
SIC Code Description
1311 Crude petroleum and natural gas
7389 Business services, not elsewhere classified
8731 Commercial physical and biological research
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Executive Officer Ian B.Walters 8/16/2022 8/1/2016
Chief Financial Officer, Secretary Allan L.Shaw 58 1/1/2023 5/12/2020
Chief Scientific Officer RobertKramer 1/8/2019 1/8/2019
8 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
SalvaRx Group Plc Commerce House, 1 Bowring Road Ramsay Isle of Man
Israel Petroleum Company, LLC P.O. Box 774327 Steamboat Springs CO United States

Business Names
Business Name
A1W4VB
BNTNF
Bontan Corporation Inc.
17 additional Business Names available in full report.

General Information
Number of Employees: 7 (As of 3/31/2023)
Outstanding Shares: 19,784,390 (As of 2/28/2024)
Stock Exchange: NASD
Fax Number: (416) 929-6612


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, April 24, 2024